Molecular Neurodegeneration

About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
December 01, 2016 - November 30, 2022
Grant ID
CA2017563
Summary
Molecular Neurodegeneration (MN) is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels https://molecularneurodegeneration.biomedcentral.com/). The current Editors-In-Chief are Guojun Bu, PhD, Mayo Clinic, USA, and Huaxi Xu, PhD, Sanford Burnham Prebys Medical Discovery Institute, USA. MN is the official journal of the BrightFocus Foundation (http://www.brightfocus.org/research/molecular-neurodegeneration-journal). The open access publishing model provides free articles to the general public, as well as scientists, clinicians, and other healthcare practitioners. MN publishes peer-reviewed, original scientific research on the causes of neurodegenerative diseases, such as Alzheimer’s or Parkinson’ and on the pre-clinical testing of potential therapies for these devastating diseases. In 2016, MN has an impact score of 6.56., meaning the journal is now the highest ranking open access neuroscience journal in the journal citation reports (JCR).
Grants
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD